A ten‑patient trial of an optogenetic gene therapy demonstrated safety and modest gains in light sensitivity for people with advanced retinitis pigmentosa.
A ten‑patient trial of an optogenetic gene therapy demonstrated safety and modest gains in light sensitivity for people with advanced retinitis pigmentosa.